Reference
Patel RA, et al. Cost variability of suggested generic treatment alternatives under the medicare part d benefit. Journal of Managed Care Pharmacy 20: 283-90, No. 4, Mar 2014. Available from: URL: http://dx.doi.org2014(20)4: 283-290 [pii]
Rights and permissions
About this article
Cite this article
Generics cost saving for Medicare beneficiaries. PharmacoEcon Outcomes News 699, 6 (2014). https://doi.org/10.1007/s40274-014-1138-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-014-1138-y